Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Nuvig Therapeutics, Inc.

News headline image
Nuvig Therapeutics Appoints Celia J.F. Lin, M.D., as Chief Medical Officer
From Nuvig Therapeutics, Inc.
Via Business Wire
News headline image
Nuvig Therapeutics Appoints David J. Woodhouse, Ph.D., as Chief Executive Officer and James Mackay, Ph.D., as Independent Board Chair
From Nuvig Therapeutics, Inc.
Via Business Wire
News headline image
Nuvig Therapeutics Announces First Patient Dosed in Phase 2 CIDP Trial of NVG-2089 and Presentation of Phase 1 Data
From Nuvig Therapeutics, Inc.
Via Business Wire
News headline image
Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator
From Nuvig Therapeutics, Inc.
Via Business Wire
News headline image
Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089
From Nuvig Therapeutics, Inc.
Via Business Wire
News headline image
Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer
From Nuvig Therapeutics, Inc.
Via Business Wire
News headline image
Nuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer
From Nuvig Therapeutics, Inc.
Via Business Wire
News headline image
Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases
From Nuvig Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.